Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 16, Issue 6, Pages 530-535
Publisher
Springer Nature
Online
2015-09-08
DOI
10.1038/tpj.2015.63
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelial Nitric Oxide Synthase Single Nucleotide Polymorphism and Left Ventricular Function in Early Chronic Kidney Disease
- (2015) Sourabh Chand et al. PLoS One
- Mitochondrial Topoisomerase I (Top1mt) Is a Novel Limiting Factor of Doxorubicin Cardiotoxicity
- (2014) S. Khiati et al. CLINICAL CANCER RESEARCH
- Polymorphisms of Asparaginase Pathway and Asparaginase-Related Complications in Children with Acute Lymphoblastic Leukemia
- (2014) M. Ben Tanfous et al. CLINICAL CANCER RESEARCH
- Hyaluronan Synthase 3 Variant and Anthracycline-Related Cardiomyopathy: A Report From the Children's Oncology Group
- (2014) Xuexia Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Endothelial Nitric Oxide Synthase Gene G894T Polymorphism and Myocardial Infarction: A Meta-Analysis of 34 Studies Involving 21068 Subjects
- (2014) Jian-Quan Luo et al. PLoS One
- Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia
- (2013) Steven E. Lipshultz et al. CANCER
- Dexrazoxane Prevents the Development of the Impaired Cardiac Phenotype in Caveolin-1-disrupted Mice
- (2013) Anne-Katrin Polanski et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Postinduction Dexamethasone and Individualized Dosing ofEscherichia ColiL-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01
- (2013) Lynda M. Vrooman et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of NOS3 DNA Variants in Externalizing Behavioral Problems Observed in Childhood Leukemia Survivors
- (2013) Sophie Marcoux et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children
- (2013) H. Visscher et al. PEDIATRIC BLOOD & CANCER
- ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia
- (2011) J. Rousseau et al. BLOOD
- ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia
- (2011) Agnes F. Semsei et al. CELL BIOLOGY INTERNATIONAL
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
- (2011) Angelo Di Leo et al. LANCET ONCOLOGY
- Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia
- (2011) M Ansari et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review
- (2010) Suman Lal et al. CURRENT DRUG METABOLISM
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
- (2010) Steven E Lipshultz et al. LANCET ONCOLOGY
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia
- (2009) M. Ansari et al. BLOOD
- Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)
- (2009) L B Silverman et al. LEUKEMIA
- Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
- (2009) Vladan Rajić et al. LEUKEMIA & LYMPHOMA
- Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice
- (2009) Shiwei Deng et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search